Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biotechnology and research: promise and problems.

J R La Montagne1

  • 1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 31, Room 7A03, Bethesda, MD 20892, USA. jm79q@nih.gov

Lancet (London, England)
|December 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adult immunization: principles and practice.

Advances in internal medicine·1999
Same author

RSV pneumonia, a community-acquired infection in adults.

Lancet (London, England)·1997
Same author

The United States research strategy on pertussis.

Developments in biological standardization·1997
Same author

Fungal infections: a growing threat.

Public health reports (Washington, D.C. : 1974)·1996
Same author

Public health implications of emerging vaccine technologies.

Pharmaceutical biotechnology·1995
Same author

Emerging infectious diseases.

The Journal of infectious diseases·1994
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Biotechnology

Area of Science:

  • Biotechnology and Biomedical Research

Background:

  • Significant global investment in basic biomedical research over the past two decades has fueled biotechnology's rapid expansion.
  • This growth has generated numerous potential health applications, attracting commercial interest from the biotechnology industry.

Purpose of the Study:

  • To examine the implications of rapid biotechnology expansion.
  • To address concerns regarding intellectual property and conflicts of interest in commercializing health innovations.
  • To emphasize the need for strengthening peer review processes.

Main Methods:

  • This study is a review and analysis of trends in biotechnology investment and commercialization.
  • It examines the impact of private investment on research and development.
  • It assesses the current state of intellectual property and conflict of interest management.
Keywords:
Biomedical and Behavioral ResearchGenetics and Reproduction

Related Experiment Videos

Main Results:

  • Biotechnology expansion is closely linked to increased private investment in commercializing health applications.
  • Concerns about intellectual property and conflicts of interest are rising alongside industry growth.
  • Existing peer review mechanisms require enhancement to keep pace with scientific and commercial advancements.

Conclusions:

  • The rapid growth of biotechnology necessitates robust oversight.
  • Strengthening peer review is crucial for maintaining scientific integrity amidst commercial pressures.
  • Balancing innovation with ethical considerations is paramount in the evolving biotechnology landscape.